Last reviewed · How we verify
NCT06723353
Effects of Visceral Manipulation Combined with Kinesio Taping on Diastasis Recti, Pain Intensity, Stress Incontinence, Pelvic Floor Strength, and Overall Wellness in Postpartum Women
NA trial testing Visceral Manipulation Therapy in Diastasis Recti in 72 participants. Currently enrolling.
31 January 2025
Quick facts
| Lead sponsor | Health and Research-Insights |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 1 May 2024 |
| Primary completion | 31 January 2025 |
| Estimated completion | 31 January 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Visceral Manipulation Therapy
- Abdominal Kinesio Taping
- Combined Visceral Manipulation and Kinesio Taping
- Postpartum Core Strengthening Program
Conditions studied
- Diastasis Recti — all drugs for Diastasis Recti →
- Diastasis Recti Abdominis (DRA) — all drugs for Diastasis Recti Abdominis (DRA) →
Sponsor
Health and Research-Insights
Who can join
Adults 35 to 45, female only, with Diastasis Recti or Diastasis Recti Abdominis (DRA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to evaluate the effectiveness of different therapies for treating Diastasis Recti Abdominis (DRA) in postpartum women. DRA, commonly experienced after childbirth, involves the separation of abdominal muscles, which can lead to discomfort and decreased core stability. The main questions this study seeks to answer are: How effective are Visceral Manipulation (VM), Kinesio Taping (KT), and core strengthening exercises in reducing the gap between abdominal muscles (Inter-Recti Distance or IRD)? Do these treatments improve pain levels, pelvic floor muscle strength, and urinary incontinence? This study will compare the effects of VM, KT, a combination of both, and core strengthening exercises to determine which therapy-or combination of therapies-most effectively treats DRA. Participants will: Be randomly assigned to one of four treatment groups: VM, KT, VM combined with KT, or core strengthening exercises. Undergo their designated treatments for a period of 6 weeks. Visit the clinic for assessments at the start, mid-point, and end of the treatment period. Complete surveys and undergo physical tests to measure changes in IRD, pain levels, pelvic floor strength, and urinary function. This research will provide valuable insights into the most effective treatments for DRA, aiming to enhance the well-being and recovery of postpartum women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06723353
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diastasis Recti
Currently open trials in the same condition.
- NCT07520409 — Effects of Drawing in Maneuver and Resisted Ankle Dorsiflexion in Postpartum Diastasis Recti · NA · recruiting
- NCT07440836 — Effects of Corrective Versus Plank Exercises on Diastasis Recti · NA · recruiting
- NCT04652830 — Naprapathy Training for Postpartum DRAM Prevention · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06723353 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Health and Research-Insights
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06723353.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing